83 related articles for article (PubMed ID: 12670927)
21. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
22. Correspondence re: S. Beá et al., BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res., 61: 2409-2412, 2001.
Raaphorst FM; Meijer CJ; Otte AP
Cancer Res; 2002 Jan; 62(2):618-9. PubMed ID: 11809719
[No Abstract] [Full Text] [Related]
23. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
[TBL] [Abstract][Full Text] [Related]
24. Endonuclease J: a site-specific endonuclease cleaving immunoglobulin genes.
Kondo S; Kataoka T; Nishi M; Kodaira M; Takeda S; Honjo T
Cold Spring Harb Symp Quant Biol; 1984; 49():661-8. PubMed ID: 6442229
[No Abstract] [Full Text] [Related]
25. Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572, 2001.
Taylor GM; O'Brien HP; Greaves MF; Ravetto PF; Eden OB
Cancer Res; 2003 Oct; 63(19):6563-4; author reply 6565. PubMed ID: 14559852
[No Abstract] [Full Text] [Related]
26. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders.
Rodig SJ; Healey BM; Pinkus GS; Kuo FC; Dal Cin P; Kutok JL
Cancer Genet Cytogenet; 2006 Nov; 171(1):44-51. PubMed ID: 17074590
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
28. Antibody repertoires generated by VH replacement and direct VH to JH joining.
Koralov SB; Novobrantseva TI; Königsmann J; Ehlich A; Rajewsky K
Immunity; 2006 Jul; 25(1):43-53. PubMed ID: 16860756
[TBL] [Abstract][Full Text] [Related]
29. Structure and consequences of IGH switch breakpoints in Burkitt lymphoma.
Guikema JE; Schuuring E; Kluin PM
J Natl Cancer Inst Monogr; 2008; (39):32-6. PubMed ID: 18647999
[TBL] [Abstract][Full Text] [Related]
30. Molecular biology: case of mistaken identity.
Bassing CH; Alt FW
Nature; 2004 Mar; 428(6978):29-31. PubMed ID: 14999268
[No Abstract] [Full Text] [Related]
31. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
32. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study.
Darby AJ; Lanham S; Soubeyran P; Johnson PW
Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451
[TBL] [Abstract][Full Text] [Related]
33. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
[TBL] [Abstract][Full Text] [Related]
34. Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products.
Wickham CL; Harries LW; Sarsfield P; Joyner MV; Ellard S
Clin Lab Haematol; 2006 Aug; 28(4):248-53. PubMed ID: 16898964
[TBL] [Abstract][Full Text] [Related]
35. Composite mantle cell and follicular lymphoma. A case report.
Ilgenfritz RB; Le Tourneau A; Arborio M; Molina TJ; Diebold J; Damotte D; Audouin J
Hum Pathol; 2009 Feb; 40(2):259-63. PubMed ID: 18755498
[TBL] [Abstract][Full Text] [Related]
36. Advances in molecular hematopathology: T-cell receptor gamma and bcl-2 genes.
Greiner TC
Am J Pathol; 1999 Jan; 154(1):7-9. PubMed ID: 9916911
[No Abstract] [Full Text] [Related]
37. Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies.
Zabalegui N; de Cerio AL; Inogés S; Rodríguez-Calvillo M; Pérez-Calvo J; Hernández M; García-Foncillas J; Martín-Algarra S; Rocha E; Bendandi M
Haematologica; 2004 May; 89(5):541-6. PubMed ID: 15136216
[TBL] [Abstract][Full Text] [Related]
38. Translocation and gross deletion breakpoints in human inherited disease and cancer II: Potential involvement of repetitive sequence elements in secondary structure formation between DNA ends.
Chuzhanova N; Abeysinghe SS; Krawczak M; Cooper DN
Hum Mutat; 2003 Sep; 22(3):245-51. PubMed ID: 12938089
[TBL] [Abstract][Full Text] [Related]
39. The malignant clone in Waldenstrom's macroglobulinemia.
Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
[TBL] [Abstract][Full Text] [Related]
40. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
